Use Of Omega-3 Fatty Acids Research Articles

Safe and well-tolerated long-term parenteral nutrition regimen: omega-3-fatty-acid-enriched Medium Chained/ Long Chained Triglycerides emulsion.

Background and AimsA limited number of randomized controlled trials (RCTs) have examined the use of lipid emulsions (LEs) of different compositions in home parenteral nutrition (HPN), and there are very few data on the long-term use of omega-3 (n-3) polyunsaturated fatty acids (PUFAs). The study´s objective was to assess safety and tolerability of an n-3 PUFA-enriched LE in adult patients suffering from chronic intestinal failure (CIF) requiring long-term HPN. MethodsIn this prospective, randomized, controlled, double-blind, multicentre, international clinical trial, which was conducted at eleven sites, adult patients in need of HPN including lipids received either the investigational product, an n-3 PUFA-enriched medium/long-chain triglyceride (MCT/LCT) LE, or the reference product, a standard MCT/LCT LE, for an average duration of eight weeks. The primary outcome was the sum of changes of liver function parameters (total bilirubin, aspartate transaminase and alanine transaminase) from baseline to final visit. Secondary objectives included fatty acid pattern in plasma and red blood cells (RBCs) and triene:tetraene ratio in plasma. Results74 patients were enrolled up to premature study termination. Liver function parameters showed no clinically relevant differences between study groups and remained within normal ranges. The n-3 PUFAs EPA and DHA increased in plasma and RBCs in the Lipidem group and were higher in the Lipidem group than the reference group at the end of the study resulting in an increased n-3-index in RBCs with Lipidem. Average n-3-index was >8. The plasma triene:tetraene ratio decreased in both groups. ConclusionThis study is one of the largest comparing two LEs in the complex setting of HPN treatment of adult patients. Although it has been early terminated its results considerably contribute to the evidence on safety and efficacy of longer-term use of LEs in HPN treatment. The n-3 PUFA-enriched LE Lipidem was safe and well-tolerated, particularly in terms of liver function. Lipidem provided an additional supply of n-3 PUFAs and led to positive changes in fatty acid profiles of plasma and RBCs. The n-3-index was in the desirable range at the end of the study in patients receiving Lipidem. There was no evidence of essential fatty acid deficiency with Lipidem. ClinicalTrials.gov IdentifierNCT03282955 Trial RegistrationEudraCT Number: 2015-000849-23

Does Omega-3 supplementation increase profuse postpartum hemorrhage? A hospital-based register study.

Although Omega-3 is thought to have anticoagulative properties, the potential untoward effects of Omega-3 during pregnancy have not been investigated. No previous studies have been made to specifically assess its effect on postpartum hemorrhage (PPH). Our aim was to determine if an association exists between Omega-3 intake during pregnancy and profuse PPH or massive PPH. Data on all deliveries that occurred at Karolinska University Hospital during the years 2007-2011 (n = 41 139) was collected from the medical record of Obstetrix, maternal health and delivery chart system. Women with reported Omega-3 use in early pregnancy were considered exposed and all other as unexposed. Bivariate and adjusted multivariate analysis was performed on main outcomes. Omega-3 use was associated with 25% increased odds of PPH (adjusted odds ratio (aOR) 1.25, 95% confidence interval [CI] (1.06-1.47)) and a more than doubled odds of massive PPH (aOR 2.36, 95% CI 1.26-4.44). In addition, there was a minor increase in the amount of blood loss. Although few, women on low-dose discontinued terminated at 36th week showed no significant association to blood loss measurements. Our observational findings showed 25% higher odds of PPH and two times higher odds of massive PPH in women who reported using Omega-3 in early pregnancy. Our findings give some support to advocate discontinued use of Omega-3 in late pregnancy.

Growth of the Omega 3 industry applied in non-surgical periodontal therapies in dental practitioners

The aim of this systematic review is to recognise the effects of dietary supplementation of Omega 3 (fatty acids) as an adjuvant in non-surgical periodontal therapy in patients with periodontitis. In the present research work, a Systematic Review of Randomised Clinical Trials on the supplementary use of Omega 3 in the diet of patients with periodontitis was carried out. The guidelines of the CONSORT 2010 statement were followed using different search equations and previously selected articles. The results show the synthesis of 12 articles selected for this study, providing information such as author, year, journal and quartile classification, among other parameters such as blood biomarkers present and periodontal clinical parameters. In conclusion, the analysis of the efficacy of Omega-3 as an adjunct to non-surgical periodontal therapy (NSPT) shows that, although improvements in clinical indicators such as calculus index (CIN), periodontal pocket depth and bleeding on probing are observed, the additional impact of Omega-3 has not been shown to be statistically significant. The variability in results may be due to differences in study designs, doses administered, and sample sizes, which limits the ability to establish a clear benefit of Omega-3 on these specific parameters.

Application of omega 3,6 with Moringa oleifera suplemented vitamin E on rumen fluid characteristics, microbial protein synthesis, and methane gas production in goats on suboptimal lands

Changes in feeding patterns were needed to overcome the problem of methane gas emissions from ruminant livestock and the problem of low productivity at the smallholder livestock level. This solution involves direct action against the gas produced in the stomach of ruminants by providing feed containing active substances to reduce the microbes that produce gas in the stomach. One alternative feed that was often used as a promoter of improving rumen fluid characteristics was the use of omega 3.6 sources together with Moringa leaves enriched with vitamin E. This research aimed to investigate the effect of feeding on methane gas production in goats. The research method used a Randomized Block Design (RAK) with four treatments and five replications in vitro. From the research results, it could be concluded that the use of omega 3.6 together with Moringa leaves enriched with vitamin E was able to reduce methane gas production by 25.62% with a Volatile Fatty Acid (VFA) value of 144.53 mM, pH around 6.99, NH3 11.87 mg/100ml, microbial biomass 20.42 mg/ml, microbial protein 217.58mg/ml, bacterial colony 5.34x109 cells/ml and protozoa population 29x106 cells/ml. This conclusion shows that the use of omega 3.6 with Moringa oleifera supplemented with vitamin E has the potential to consistently improve rumen fluid characteristics and reduce methane gas emissions by using a combination of omega 3.6 sources and Moringa leaves in suboptimal land, as well as vitamin E supplementation.

Impact of metformin versus metformin plus omega_3 on inflammatory outcomes in a tester of Iraqi women with PCOS

Background: Polycystic ovary syndrome signifies a state of chronic inflammation, which is partly caused by excessive visceral adipose tissue and the pro-inflammatory mechanisms associated with it. Interestingly, even normal-weight women with PCOS exhibit long-lasting low-flat inflammation characterized via raised ranks cytokines of pro-inflammatory. This can be attributed to the presence of surplus visceral adipose tissue and intraperitoneal fat depots in normal-weight PCOS patients as well. Aim of the study: To estimate the influence of metformin and omega-3 treatment on serum ranks of IL-18 and highly sensitive CRP in females with PCOS. Patients and methods: The present interventional prospective study included 90 sick with an age assortment of 18 to less than 40 years. Those patients were analyzed with polycystic ovarian disease (PCOS) founded on Rotterdam principles (Rotterdam, 2004) by 2 specialists in obstetrics and gynecology. The patients were recruited from the Maternity and Pediatrics Teaching Hospital in Adiwaniyah Province, Iraq. The training is outmoded back to September the 21st 2023 and extended to March 31st 2024. Results: Following treatment, both metformin+Omega3 and metformin alone were able to reduce mean IL-18 significantly (p < 0.001 versus p < 0.001, separately); however, the amount of decrease caused by combination was more than that caused by metformin alone significantly, 158.62 pg/ml versus 71.14 pg/ml , respectively (p = 0.048). Both metformin+Omega3 and metformin alone were able to reduce mean hs-CRP significantly (p < 0.001 versus p < 0.001, respectively); however, the amount of decrease caused through combination was more than that caused by metformin alone significantly, 157.69 mg/L versus 61.27 mg/L , separately (p = 0.032). Conclusion: The use of Omega3 has an efficient and safe synergistic effect when added to metformin in reducing IL-18 and hs-CRP in sick with PCOS, thus, suggesting an anti-inflammatory property for such combination.

Cultural barriers and new technologies of translation: Using Omega T in translating idioms

Technologies of translation have known an impressive interest of translators and researchers. The world seems very small due to the latest advancement of technology. This development raised the need for translation to overcome language barriers. English, for instance, is considered as the language of international communication. This state of affairs increases the demands for translation from and into English. In order to respond to the huge number of translation demands, many translators choose to employ machine translation and computer aided translation tools. These technologies have undoubtedly contributed in delivering good and fast translation. However, some problems have been seen concerning the quality of translation. One of the main disadvantages of translation technologies is rendering effective meaning in cultural contexts. This paper aims to spotlight on the major problems of translating cultural aspects using technologies of translation. It tries to investigate the case of translating idioms from English into Arabic using translation memory tools, precisely Omega T as an assisting tool. Therefore, an experiment was designed at the department of English to examine the students’ performance. The findings revealed that the use of Omega T plays a significant role in enhancing the quality of students’ translation of idioms.

Omega-3/omega-6 fatty acids: Effects on growth and neurodevelopment of the fetus and preterm infant. A narrative review

BACKGROUND: Fatty acids of the omega-3/omega-6 groups are used in cases of pregnancy, lactation and preterm birth. In recent decades, pediatrics has been trying to find out whether the use of omega-3/omega-6 has effects on human growth and neurodevelopment. A total of 44 original articles on the topic of omega-3/omega-6 and human growth and nutrition, in gynecology and pediatrics have been selected on PubMed from January 1979 until March 2023. Significant critical issues emerged regarding published studies, despite encouraging evidence on the usefulness of omega-3/omega-6 used in pregnancy, lactation, states of malnutrition, and inflammatory processes, while data on the efficacy of use in fetal, neonatal, and pediatric patients are conflicting. Critical structural and functional issues emerge in the studies that may call into question the validity of the results. The data are encouraging and suggest that certain aspects of the type of administration and dosages of omega-3/omega-6 fatty acid supplementation should be investigated further to help demonstrate the clinical validity of such prescriptions, especially in terms of gestational maturation, growth, and human nutrition in clinical practice in Gynecology and Pediatrics.

Flash'O real-world evidence programme - Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries.

The Flash'O project was designed to provide insights into the current use of prescription omega-3 and their perceived benefits by physicians in real-world clinical practice, in Russia, Saudi Arabia, Thailand, and Gulf countries, and to determine the adherence of physicians to dyslipidemia management guidelines. The present study focuses on Flash'O's process and results in Middle East countries. A total of 338 physicians and specialists completed the online questionnaire. Most responding physicians were male (91.7%), general practitioners (42.6%) with more than 5 years of seniority (80.4%) and saw more than 50 patients a week (71.5%). Most surveyed physicians (64.2%) reported using guidelines in their daily practice for the management of their patients with dyslipidemia. They mostly followed national guidelines (68.6%). American or European ones were less commonly used. Responding physicians thought that omega-3 supplementation could be more beneficial in all types of dyslipidemia, except high non- hight density lipoproteins, and for patients suffering from obesity, type 2 diabetes mellitus, acute coronary syndrome with ST-segment elevation myocardial infarction and high cardiovascular diseases risk (score ≥ 5% and < 10%), but less beneficial in chronic kidney disease. Respondents recommended omega-3 to their patients mainly after statin treatment in patients with dyslipidemia and for the treatment of dyslipidemia. This survey confirmed that omega-3 fatty acids are at the heart of the cardiovascular medical strategy.

Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders.

Omega-3 polyunsaturated fatty acids (PUFA) have demonstrated anti-inflammatory properties, while Omega-6 have pro-inflammatory effects, and the balance between the two is an important aspect of healthy nutrition. Over the last 30 years, however, the Western diet has shifted largely from Omega-3 to Omega-6 consumption. Uncontrolled aberrant and chronic inflammation is a leading component of many common diseases, including arthritis, cardiovascular diseases, neurodegenerative diseases, cancer, obesity, autoimmune diseases, and infective diseases. Eicosanoids derived from Omega-6 participate in the inflammatory process, while Omega-3 PUFA have the opposite effect. Many favorable effects of Omega-3 are believed to result from their anti-inflammatory properties, but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) also have inhibitory effects on immune cells and reduce proinflammatory cytokine release. All these mechanisms can be beneficial in autoimmunity. No effective preventions or definite cures for autoimmune diseases are yet known because pathophysiology is also unclear. Omega-3 fatty acid supplementation is associated with a significant reduction in disease activity in several autoimmune diseases, like type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS). Studies of viral diseases, including COVID-19, show improvement in symptom severity, recovery prognosis, and probability of survival with the use of Omega-3. Finally, the evidence of the beneficial effect of Omega-3 on metabolic diseases associated with aging is persuasive; various studies have demonstrated that their consumption improves lipids, fatty liver disease, obesity, cognitive function, and cardiovascular complications of chronic kidney disease (CKD). Omega-3 PUFA have also been shown to support an anti-inflammatory effect in older age and to have favorable effects on age-related disease's complications, frailty, and mortality. A healthy Omega-6/3 PUFA ratio should be targeted for the modulation of low-grade inflammation, as well as for the prevention of immune dysregulation and complications of uncontrolled inflammation triggered by infections, development, and progression of autoimmune disorders, and the consequences of oxidative stress due to aging. There is still a need for randomized clinical studies to validate current evidence supporting supplementation with correct doses of Omega-3 PUFA in autoimmune and chronic disease prevention.

Review of Omega-3’s Health Benefits in Parkinson’s Disease and Students Survey

In this study, a literature search and review were conducted on the beneficial effects of omega-3 in Parkinson’s Disease (PD) along with a survey of pharmacy students. This survey was completed at Howard University College of Pharmacy as part of a Drug Informatics course, where first-year Doctor of Pharmacy students were taught how to conduct literature searches. The literature search retrieved a sufficient number of studies to support the use of omega-3 in PD. Based on this, a survey tool was developed and administered. A total of 42 student respondents participated in the survey. The survey questionnaire incorporated demographics, knowledge, and opinion-based questions. There were a set of knowledge and opinion-based questions included. The results show that on the overall knowledge-based questions, only a little over half of the participants (n=25; 59.5%) answered them accurately, which indicates limited knowledge among the participants. Among the knowledge questions, the highest number of accurate responses (n=30; 71.4%) was acquired for the statement that one should avoid eating foods high in fat or cholesterol while taking omega-3, since they also contain omega-3. Regarding the opinion questions, the respondents were divided evenly (50%; n=21) in most of the opinion questions. The question that acquired the highest variance was the one that refers to the belief that omega-3 supplement reduces the signs and symptoms of PD (mean 2.29+1.02). Overall, even though there are multiple studies that supported the beneficial use of omega-3, in this study, we found a limited knowledge and a wide variance of opinions among the study participants.

Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes

BackgroundResveratrol and omega-3 have been shown to prevent atherosclerosis. However, histopathological changes and their comparison have not been studied well. This study investigated the therapeutic effects of resveratrol and omega-3 in experimental atherosclerosis of mice.MethodsWe divided sixty 6-week-old male C57BL/6 mice into six groups and followed for 10 weeks: (1) standard diet, (2) atherogenic diet, (3) atherogenic diet along with resveratrol from the start of the sixth week, (4) atherogenic diet along with omega-3 from the start of the sixth week, (5) standard diet along with resveratrol from the start of the sixth week, (6) standard diet along with omega-3 from the start of the sixth week.ResultsThe mice fed on an atherogenic diet had a larger fat area and a thicker aortic wall thickness than mice fed on a standard diet. The use of omega-3 and resveratrol in the mice with an atherogenic diet resulted in a significantly reduced fat area (p-value = 0.003), and resveratrol had a significantly higher effect. Omega-3 or resveratrol induced a significant reduction in aortic wall thickness in mice on an atherogenic diet, and there was no significant difference between them. Among the mice with a standard diet, this study did not observe any significant changes in the fat area or the aortic wall thickness with the consumption of omega-3 or resveratrol.ConclusionsResveratrol and omega-3 had a regressive and therapeutic role in atherosclerosis, with a more significant effect in favor of resveratrol.

Morphological changes in the neurons of the parietal cortex and hippocampus of rats with subtotal cerebral ischemia under conditions of the use of modulators of the L-arginine-NO pathway and against the background of the administration of Omega-3 pol

Cerebrovascular diseases of ischemic genesis tend to increase, rejuvenate, are associated with severe clinical course, high rates of disability and mortality. The urgency of the problem of cerebrovascular diseases can rightfully be defined as extraordinary, requiring the concentration of efforts of specialists of different profiles to solve it. Subtotal cerebral ischemia leads to the development of morpho functional disturbances of the cerebral cortex. The introduction of Omega-3 polyunsaturated fatty acids has a corrective effect on the hippocampus in conditions of subtotal ischemia, reducing the number of shadow cells and hyperchromic shrunken neurons, without significantly affecting the size and shape of neurons in the cerebral cortex. Prior administration of L-NAME, the use of Omega-3 did not prevent the effects of the NO synthase inhibitor and associated NO deficiency at this dose and route of administration.

Omega-3/omega-6 fatty acids: The effects on the psychophysical well-being of adolescents and adults

Background: Fatty acids of the omega-3/omega-6 groups are used especially in cases of pregnancy, lactation, and malnutrition. In recent decades, pediatrics has been trying to find out whether the use of omega-3/omega-6 has effects on human growth and neurodevelopment. Aims: Check the state of the art on the use of omega-3/omega-6 type fatty acids in the diet, in adolescent and adult populations. Materials and methods: A total of 72 original articles on the topic of human growth and nutrition in pediatrics have been selected on PubMed through September 2022. Results: In literature, the use of omega-3/omega-6, with greater prevalence in the former group than the latter group, appears to be most effective in hypertension hypothesis, dyslipidemia, and high C-reactive protein values, cardiovascular risk, and neuropathic pain, while appearing to have less impact on neurodegenerative (except in multiple sclerosis) and mental disorders (except in depression). Interesting benefits can be detected when combining omega-3/omega-6 with spirulina algae, chitosan, probiotics, vitamin D, fiber and plant extracts. Conclusion: Significant evidence emerges on the importance of omega-3 and omega-6 fatty acid supplementation, but important structural shortcomings of research designs still emerge from the published studies; moreover, many studies assume that fatty acid supplementation can have a curative effect on already active diseases, when in fact such prescriptions should be considered as adjuvant therapies to prevent or promote symptomatic regression, precisely because of their anti-inflammatory, antioxidant and immunomodulating virtues. However, there is no concrete and robust evidence of the positive impact on psychological well-being. Future research that can resolve the critical issues highlighted is hoped to promote a better approach to the topic of omega-3/omega-6 supplementation in human health.

Final Efficacy and Cost Analysis of a Fish Skin Graft vs Standard of Care in the Management of Chronic Diabetic Foot Ulcers: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Introduction. DFUs remain a cause of significant morbidity. Objective. This is the third of 3 planned articles reporting on a prospective, multicenter, randomized controlled trial evaluating the use of omega-3–rich acellular FSG compared with CAT in the management of DFUs. Materials and Methods. A total of 102 patients with a DFU (n = 51 FSG, n = 51 CAT) participated in the trial as ITT candidates, with 77 of those patients included in the PP analysis (n = 43 FSG, n = 34 CAT). Six months after treatment, patients with healed ulcers were followed up for ulcer recurrence. A cost analysis model was applied in both treatment groups. Results. The proportion of closed wounds at 12 weeks was compared, as were the secondary outcomes of healing rate and mean PAR. Diabetic foot wounds treated with FSG were significantly more likely to achieve closure than those managed with CAT (ITT: 56.9% vs 31.4%; P =.0163). The mean PAR at 12 weeks was 86.3% for FSG vs 64.0% for CAT (P =.0282). Conclusions. Treatment of DFUs with FSG resulted in significantly more wounds healed and an annualized cost savings of $2818 compared with CAT.

Use of omega-3 as adjunctive therapy in the control of hyperlipidemia in metabolic and endocrine diseases in dogs

Omega-3 from fish is commonly recommended for the control of hyperlipidemia, however, there are few studies in dogs proving its efficacy, and no studies have compared doses of omega-3 in patients with severe hyperlipidemia.

Omega-3 Fatty Acids for the Management of Osteoarthritis: A Narrative Review.

Osteoarthritis (OA) is a disease which results in degeneration of cartilage within joints and affects approximately 13.6% of adults over 20 years of age in Canada and the United States of America. OA is characterized by a state of low-grade inflammation which leads to a greater state of cellular catabolism disrupting the homeostasis of cartilage synthesis and degradation. Omega-3 polyunsaturated fatty acids (PUFAs) have been postulated as a potential therapeutic treatment option for individuals with OA. Omega-3 PUFAs are recognized for their anti-inflammatory properties, which could be beneficial in the context of OA to moderate pro-inflammatory markers and cartilage loss. The purpose of this narrative review is to outline recent pre-clinical and clinical evidence for the use of omega-3 in the management of OA.

The effect of omega-3 fatty acids on active periodontal therapy: A systematic review and meta-analysis.

"Host modulatory therapy" (HMT) with ω-3 fatty acids aims at reducing inflammation. With HMT as an adjunct, a better result of periodontal therapy is expected. The aim of this systematic review and meta-analysis (MA) was to examine the additional effect of ω-3 fatty acids to non-surgical periodontal therapy (SRP) on the probing pocket depth (PPD) and the clinical attachment level (CAL). MEDLINE-PubMed and Cochrane-CENTRAL libraries were searched up to January 2021 for randomized controlled trials in patients with chronic periodontitis, treated with SRP/placebo as controls and SRP/ω-3 fatty acids as the test group. The search identified 173 unique abstracts, and screening resulted in 10 eligible publications. Descriptive analysis showed a significant effect on the PPD and CAL in favour of the groups with ω-3 fatty acids in the majority of comparisons. MA revealed that adjunctive use of ω-3 fatty acids to SRP resulted in 0.39 mm more PPD reduction (95% CI: -0.58; -0.21) and 0.41 mm more CAL gain (95% CI: -0.63; -0.19) than SRP alone. In patients with periodontitis, dietary supplementation with ω-3 fatty acids as an adjunct to SRP is more effective in reducing the PPD and improving the CAL than SRP alone. If SRP is indicated, the use of ω-3 fatty acids can be considered for a moderate extra added effect on PPD reduction and CAL gain. The strength of this recommendation is moderate.

A Recycling Alternative for Expanded Polystyrene Residues Using Natural Esters

The objective of this research is to provide a new recycling method for one of the most consumed plastics today, since it is used for the manufacture of a wide variety of industrial products, which leads to an environmental problem caused by incorrect handling and final disposal. The dissolution of expanded polystyrene waste was evaluated by using natural esters for its post treatment and recovery. The use of omega-3 as a natural solvent creates an opportunity to take advantage of natural biomass, since it can be obtained from the residues from fishing activities, this being an economic advantage for obtaining raw material and also friendly with the environment. For the development of this research, expanded polystyrene containers were dissolved in omega-3, glyceryl tributyrate, and ethyl butyrate; methanol and isopropanol were used for its recovery. The characterization of the recovered material was carried out with thermogravimetric analysis, differential scanning calorimetry, scanning electron microscopy, infrared spectroscopy and X-ray powder diffraction techniques. The experimental data obtained indicated that the use of these esters is a good alternative for the recycling of expanded polystyrene.

Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.

We discuss current controversies in the clinical use of omega-3 fatty acids (FA), primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and examine discrepancies between recent trials. Furthermore, we discuss potential side effects reported in these studies and the role of mixed omega-3 FA dietary supplements and concerns about their use. REDUCE-IT showed that addition of icosapent ethyl, a highly purified form of EPA, can reduce risk of cardiovascular events among statin-treated individuals with high triglycerides. Additional supportive evidence for EPA has come from other trials and meta-analyses of omega-3 FA therapy. In contrast, trials of mixed EPA/DHA products have consistently failed to improve cardiovascular outcomes. Discrepancies in results reported in RCTs could be explained by differences in omega-3 FA products, dosing, study populations, and study designs including the placebo control formulation. Evidence obtained from highly purified forms should not be extrapolated to other mixed formulations, including "over-the-counter" omega-3 supplements. Targeting TG-rich lipoproteins represents a new frontier for mitigating ASCVD risk. Clinical and basic research evidence suggests that the use of omega-3 FA, specifically EPA, appears to slow atherosclerosis by reducing triglyceride-rich lipoproteins and/or inflammation, therefore addressing residual risk of clinical ASCVD.

Passion for omega: Role of omega‑3 PUFAs during pregnancy for health of offspring

The basis of the normal course of pregnancy is optimal nutrition as one of the main elements of a healthy lifestyle. Numerous studies have established that long-chain omega 3 polyunsaturated fatty acids (PUFAs) have a variety of biological activities: anti-inflammatory, antioxidant, immunomodulatory, antiallergic, antithrombotic, antisclerotic, etc. Eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are necessary for the normal functioning of the body during pregnancy and intrauterine development of the child. Deficiency of omega 3 PUFAs leads to a disruption in the normal development and physiological formation of the structures of the brain, visual analyzer and the immune system of the fetus. The use of omega 3 PUFAs during pregnancy has a positive effect both on the neuropsychic state of the woman, preventing depression, and on the psychomotor development of the child, improving cognitive functions. It is important to ensure adequate intake of these compounds from food or dietary supplements to ensure the normal course and outcome of pregnancy.